Class IOngoing

Adrenalin Chloride Solution (Epinephrine Nasal Solution recall

FDA recall D-0223-2025 · initiated Dec 20, 2024

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)

Details

Product: Adrenalin Chloride Solution (Epinephrine Nasal Solution, USP), 30mg/30mL (1mg/mL), packaged in 30 mL vials, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-103-01
Recalling company: Endo Pharms
Classification: Class I
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: USA nationwide.
Initiated: Dec 20, 2024
FDA report date: Feb 12, 2025

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0223-2025 ↗

← All drug recalls